A new study links baseline IFN-γ-based NK cell activity to ex vivo expansion capacity of autologous NK cells, offering a ...

Tumours rely on surrounding cells, including cancer-associated fibroblasts, immune cells and blood vessels, to grow, spread ...

Researchers have uncovered a previously overlooked immune cell that can recognize and kill small cell lung cancer, the most ...

Immature natural killer cells in donor cord blood can sabotage engineered immune cells before they even reach the tumour.

Researchers used a CRISPR screen to identify a key molecular pathway that drives exhaustion in cancer-fighting immune cells, ...

USC scientists have discovered a way to create a potentially renewable supply of genetically engineered immune cells that can attack cancer and strengthen the body's natural defenses. By growing and ...

Cancer immunotherapy can lose its punch when tumor-fighting T cells become exhausted, but researchers may have found a way to keep them going longer. Scientists at Memorial Sloan Kettering Cancer ...

Colorectal cancer has become the leading cause of cancer-related death for people under 50. Its most common forms generally ...

Mixed results from population-based studies, but new lab data may offer clues to an explan ...

T cells as potent killers of small-cell lung cancer, with their genetic signature potentially revealing patients who could ...

Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel ...

A preliminary French feasibility study detected circulating tumor cells in the blood of patients during laparoscopic surgery ...